ClinicalTrials.govpublic full text
A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.
epithelial ovarian cancer, polymerisation inhibitor (parpi), parpi re-treatment, brca1/2 (+ve), brca1/2 (-ve), olaparib, ovarian cancer, progression free survival (pfs), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 880706
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.